Wedbush cuts Aclaris Therapeutics target to $8 from $10
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Transportadora de Gas del Sur Reports Quarterly Results
The company reported results for the quarter ended September 30; no financial figures are provided.
M impact | EQUITY | Oct 30, 2026, 12:25 AM UTC
Amazon shares fall as AI spending accelerates cash outflow
Amazon's cloud business is performing well, but AI investment is accelerating cash outflow.
M impact | EQUITY | Oct 30, 2026, 12:24 AM UTC
Bambusa Offers All Shares
Bambusa is offering all of its shares.
M impact | EQUITY | Oct 30, 2026, 12:23 AM UTC
Bambusa Upsizes IPO to 10.6 Million Shares at $16 Per Share
M impact | EQUITY | Oct 30, 2026, 12:23 AM UTC
Kolmar Korea to Hold Q3 Results Call for Analysts on Nov. 6
Kolmar Korea plans to present its third-quarter results on an analyst conference call at 10:30 a.m. on Nov. 6, 2026.
M impact | EQUITY | Oct 30, 2026, 12:21 AM UTC
Kolmar Korea to Host Q3 Results Call for Analysts
M impact | EQUITY | Oct 30, 2026, 12:21 AM UTC